Netuberkulózní mykobakteriální onemocnění - editorial

Stanislav Losse

Vnitr Lek 2019, 65(5):333-336 | DOI: 10.36290/vnl.2019.059  

Neuroendokrinní nádory tymu - editorial

Lenka Ostřížková

Vnitr Lek 2019, 65(5):337  

Compliance with ethical rules for scientific publishing in biomedical Open Access journals indexed in Journal Citation Reports

Jiří Kratochvíl, Lukáš Plch, Eva Koriťáková

Vnitr Lek 2019, 65(5):338-347 | DOI: 10.36290/vnl.2019.061  

This study examined compliance with the criteria of transparency and best practice in scholarly publishing defined by COPE, DOAJ, OASPA and WAME in Biomedical Open Access journals indexed in Journal Citation Reports (JCR). 259 Open Access journals were drawn from the JCR database and on the basis of their websites their compliance with 14 criteria for transparency and best practice in scholarly publishing was verified. Journals received penalty points for each unfulfilled criterion when they failed to comply with the criteria defined by COPE, DOAJ, OASPA and WAME. The average number of obtained penalty points was 6, where 149 (57.5%) journals received...

Limited ambulatory night sleep testing in patients with a suspicion of sleep apnoea syndrome: Is its indication tenable?

Milan Sova, Samuel Genzor, Petra Palyzová, Jana Zapletalová, Amjad Ghazal Asswad, Vítězslav Kolek

Vnitr Lek 2019, 65(5):348-351 | DOI: 10.36290/vnl.2019.062  

Introduction:Ambulatory sleep testing is nowadays an available diagnostic method, measuring air flow and blood oxygen saturation in patients with a suspicion of obstructive sleep apnoea syndrome (OSAS). It can be performed by either a general practitioner or an ambulatory specialist in various fields. Using this simple screening method it is possible to exclude subjects without OSAS, who therefore do not require further sleep testing at a sleep laboratory. There is no published data regarding the use of ambulatory sleep testing by sleep laboratories in the Czech Republic. The aim of this study was to evaluate the proportion of...

Surgical treatment of chronic thromboembolic pulmonary hypertension

Matúš Nižňanský, David Ambrož, Tomáš Prskavec, Pavel Jansa, Jaroslav Lindner

Vnitr Lek 2019, 65(5):353-358 | DOI: 10.36290/vnl.2019.063  

Chronic thromboembolic pulmonary hypertension (CTEPH) is a disease characterized by a mean pulmonary artery pressure that exceeds 25 mm Hg and is caused by intraluminal thrombi organisation, stenosis and occlusions of pulmonary artery and its branches and peripheral vascular remodelation. It is a chronic complication of acute pulmonary embolism. The obstruction of pulmonary artery branches increases pulmonary vascular resistance (PVR) and this leads to the right ventricular overload and right-sided heart failure. The treatment of choice is surgical pulmonary endarterectomy (PEA), a procedure that is performed in deep hypothermic cardiac arrest. The...

Communication with cancer patient

Jana Halámková, Ondřej Sláma, Dagmar Adámková Krákorová, Regina Demlová, Josef Kuře

Vnitr Lek 2019, 65(5):359-362 | DOI: 10.36290/vnl.2019.064  

The oncological patients meet the diverse physicians in the different stages of their illness. It is important for other physicians to know a basic rules of supportive effective communication. There are big differences between patients in the communication style and type of information they accept. Patient's information requirements may also change at various stages of the disease. Providing bad news is a frequent and important communication challenge for physicians. Internationally recognized and proven recommendation for communication is the six steps known as the SPIKES. Prolonging survival of cancer patients means not only communicating disease...

Multimodal treatment of thymic carcinoid: a case report

Radka Cahajlová, Mária Černá, Soňa Kiňová

Vnitr Lek 2019, 65(5):363-368 | DOI: 10.36290/vnl.2019.065  

Thymic carcinoid account for cca 0.4 % of all carcinoid tumors in the body [1]. As compared to other neuroendocrinne tumors, high rates of reccurences after surgery, more aggressive behaviour and relatively high rates of paraneoplastic syndromes are characteristic for thymic carcinoid. The mainstay of treatment is radical surgery [2-4]. Therapy of locally advanced and metastatic stages is influenced by other neuroendocrinne tumors'guidelines. We present a case report of patient with locally advanced, atypical thymic carcinoid, treated with different modalities, including newer procedures like peptide radionuclide receptor therapy (PRRT).

Nontuberculous mycobacterial disease: a case report-based review

Marcela Královcová, Thomas Karvunidis, Jaroslav Raděj, Martin Matějovič

Vnitr Lek 2019, 65(5):369-375 | DOI: 10.36290/vnl.2019.066  

Nontuberculous mycobacterial infections are rare diseases. However, as number of immunocompromised patients is growing and modern diagnostic tools are available, both the importance and incidence of nontuberculous mycobacterial infections are gaining clinical importance. Based on a clinical case, this article briefly summarizes the current knowledge on this issue.

Use of idarucizumab in clinical practice: a case report

Libuše Husová

Vnitr Lek 2019, 65(5):377-378 | DOI: 10.36290/vnl.2019.067  

Budd-Chiari syndrome is a serious condition which in chronic course leads to the development of liver cirrhosis. Anti-coagulant treatment of this syndrome is fully indicated and in the treatment can be used dabigatran. Advanced cirrhosis of the liver due to this disease can be an indication for a liver transplant. In this case, it is a great advantage the existence of an antidote to dabigatran (idarucizumab) in order to adjust the coagulation ratios and prevent bleeding disorders. Referred to a case report describes the first experience with idarucizumab in context with liver transplant in a patient with Budd-Chiari syndrome

Jan Švihovec, Jan Bultas et al (eds). Farmakologie

Milan Kriška

Vnitr Lek 2019, 65(5):392  

Jan Krejsek, Ctirad Andrýs, Irena Krčmová. Imunologie člověka

Jindřich Lokaj

Vnitr Lek 2019, 65(5):393  

Petr Jakubec, Vítězslav Kolek. Pneumonie pro klinickou praxi

Jiří Vlček

Vnitr Lek 2019, 65(5):394  

Otto Kahler and his family: II. Ripening years in Prague

Pavel Čech

Vnitr Lek 2019, 65(5):379-389 | DOI: 10.36290/vnl.2019.068  

Otto Kahler (1849-1893), a son of a wound physician at the Provincial Prison, spent his childhood and youth in his native Prague. After graduated from Charles-Ferdinand University (1871, 1872) he became a second-generation physician in an old German-Czech peasant family. He thereafter worked as an intern (from 1873) and assistant (from 1875) with Prof. Joseph Halla at the IInd Medical Clinic of the General Hospital. Shortly before habilitation (1878), in collaboration with Arnold Pick from the Insane Asylum, he began an intense research on pathology and pathological anatomy of the central nervous system (1878-1880) which resulted in discovery of the...

Korespondence ke článku. Adam Z et al. Remise "the disease associated/related with imunoglobulin IgG4" provázeného mnohočetnou lymfadenopatií po léčbě rituximabem a dexametazonem: kazuistika

Luděk Pour

Vnitr Lek 2019, 65(5):390